İstanbul Medeniyet Üniversitesi
Akademik Veri Yönetim Sistemi
Prof.Dr. MAHMUT GÜMÜŞ
Kişisel Bilgiler ve İletişim Bilgileri
Birim : TIP FAKÜLTESİ
Bölüm : DAHİLİ TIP BİLİMLERİ
Ana Bilm Dalı : İÇ HASTALIKLARI
Sabit Telefon : -
E Posta Adresi : mahmut.gumusmedeniyet.edu.tr | mgumussuperonline.com
Web Adresi :
Ofis : Merdivenköy Pol.Tıbbi Onkoloji Pol
Eğitim Bilgileri
Tıpta Yandal Uzmanlık, MARMARA ÜNİVERSİTESİ, Tıp Faültesi, Tıbbi Onkoloji BD, 2000-2003
Tıpta Uzmanlık, Sağlık Bakanlığı, Dr.Lütfi Kırdar EAH, İç Hastalıkları Kliniği, 1994-1998
Lisans, İSTANBUL ÜNİVERSİTESİ, İstanbul Tıp Fakültesi, , 1983-1989
Sertifika, Kurs ve Eğitimler
Yönetim Yeteneklerini Geliştirme, Partner Danışmanlık, 2011
Araştırma Alanları
Onkoloji
Sindirim Sistemi Kanserleri
Üniversiteler Arası Kurul Bilim Alanı Bilgileri
Sağlık Bilimleri Temel Alanı
Tıbbi Onkoloji (İç Hastalıkları)
Web Of Science Araştırma Alanları
Oncology
Medicine, General & Internal
Akademik Ünvanlar ve Görevler
Prof.Dr., İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ, 2016 - Devam Ediyor
Prof.Dr., BEZMİALEM VAKIF ÜNİVERSİTESİ, TIP FAKÜLTESİ, 2014 - 2016
Prof.Dr., KIRKLARELİ ÜNİVERSİTESİ, SYO, 2011 - 2014
Doç.Dr., MARMARA ÜNİVERSİTESİ, TIP FAKÜLTESİ, 2006 - 2011
Mesleki ve İdari Deneyimler
Üniversite Yönetim Kurulu Üyesi, İSTANBUL MEDENİYET ÜNİVERSİTESİ , , 01.11.2016 - Devam Ediyor
Etik Kurul Başkanı, BEZMİALEM VAKIF ÜNİVERSİTESİ Girişimsel Olmayan Araştırmalar Etik Kurulu, , 02.05.2016 - 30.09.2016
Rektörlüğe Bağlı Komisyon Üyesi, BEZMİALEM VAKIF ÜNİVERSİTESİ Mevzuat Komisyonu Başkanı, , 02.06.2014 - 30.09.2016
Üniversite Yönetim Kurulu Üyesi, BEZMİALEM VAKIF ÜNİVERSİTESİ , , 04.03.2014 - 01.06.2015
Rektör Danışmanı, BEZMİALEM VAKIF ÜNİVERSİTESİ , , 03.02.2014 - 01.06.2015
Yönetilen Tezler
Tıpta Uzmanlık, M.Garip, "MEME KANSERİ NEDENİYLE OPERE OLAN HASTALARDA MEME KORUYUCU CERRAHİ VEYA RADİKAL MASTEKTOMİ KARARINI ETKİLEYEN FAKTÖRLER VE CERRAHİ TÜRÜNÜN HASTA ÜZERİNDEKİ ETKİLERİ", KARTAL EĞİTİM ve ARAŞTIRMA HASTANESİ AİLE HEKİMLİĞİ TIBBİ ONKOLOJİ, Ocak, 2008.
Jüri Üyelikleri
Doçentlik, Doçentlik Sınav Jürisi, ÜAK, Nisan, 2016
Tez Savunma, Tıpta Uzmanlık Tez Savunması, ADLİ TIP ENSTİTÜSÜ, Kasım, 2016
Doçentlik, Doçentlik Sınav Jürisi, ÜAK, Ekim, 2015
Doçentlik, Doçentlik Sınav Jürisi, ÜAK, Şubat, 2015
SCI,SSCI,AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
Inal A., Kodaz H., Odabas H., Duran A., Seker M., Inanc M., et al., "Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)", JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, pp.578-582, 2018
Sevinc A., Ozkan M., Ozet A., Dane F., Oksuzoglu B., Isikdogan A., et al., "Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia", ONCOTARGETS AND THERAPY, vol.11, pp.419-426, 2018
Mutlu H., Bilican F., Mutlu H., Gümüş M. , "A comparison of metacognitive factors among patients with cancer and the control group.", PSYCHO-ONCOLOGY, vol.27, pp.1277-1283, 2018
Aygen B., Demir A., Gümüş M. , Karabay O., Kaymakoğlu S., Köksal A., et al., "Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.", TURKISH JOURNAL OF GASTROENTEROLOGY, vol.29, pp.259-269, 2018
Ercelep O., Ozdemir N., Turan N., Topcu T., Uysal M., Tanrıverdi O., et al.,"Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas.", CURRENT PROBLEMS IN CANCER, vol.-, 2018
Paz-Ares L., Luft A., Vicente D., Tafreshi A., Gümüş M. , Mazieres J., "Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer ", NEW ENGLAND JOURNAL OF MEDICINE, vol.0, no.0, pp.0-0, 2018 (Link)
Ercelep O., Gümüş M. , "Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience.", CURRENT PROBLEMS IN CANCER, vol.-, 2018
Ercelep O., Ozcelik M., Gümüş M. , "Association of lymphadenectomy and survival in epithelial ovarian cancer.", CURRENT PROBLEMS IN CANCER, vol.-, 2018
Kaya S., Aktas B., Tanrikulu S.E., Akif O.M., Dede F., Kaya H., et al., "Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.", JOURNAL OF BUON, vol.22, pp.1191-1198, 2017
Demirci A., Alkis N., Dane F., Durnalı A., Yazıcı Ö., Rzayev R., et al.,"Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study.", ASİA-PACİFİC JOURNAL OF CLİNİCAL ONCOLOGY, vol.-, 2017
Aksoy A., Odabas H., Kaya S., Bozkurt O., Degirmenci M., Topcu T., et al., "Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.", SAUDİ MEDİCAL JOURNAL, vol.38, pp.156-162, 2017
Bellmunt J., De Wit R., Vaughn D.J., Fradet Y., Lee J.-., Fong L., et al.,"Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma", NEW ENGLAND JOURNAL OF MEDİCİNE, vol.376, pp.1015-1026, 2017 (Group Author(s): KEYNOTE-045 Investigators )
Gümüş M. , Bilici A., Odabas H., Ustaalioglu B., Kandemir N., Demirci U., et al., "Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.", WORLD JOURNAL OF UROLOGY, vol.35, pp.1103-1110, 2017
Ozcelik M., Odabas H., Ercelep O., Yuksel S., Mert A.G., Aydin D., et al., "The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.18, pp.617-624, 2016
Ozcelik M., Seker M., Eraslan E., Koca S., Yazilitas D., Ercelep O., et al., "Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology", TUMOR BIOLOGY, vol.37, pp.5231-5237, 2016
Kaya S., Gümüş M. , Gurbuz Y., Cabuk D., Acikgoz O., Temiz S., et al., "The prognostic value of β-catenin and LEF-1 expression in patients with operable gastric carcinoma.", AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, vol.8, pp.1228-36, 2016
Dinc N., Aydın K., Odabas H., Ercelep O., Tufan G., Seker M., et al., "Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer.", ONCOLOGY RESEARCH AND TREATMENT, vol.39, pp.130-4, 2016
Ozcelik M., Korkmaz T., Odabas H., Gemici C., Ercelep O., Yuksel S., et al., "Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients", TUMOR BIOLOGY, vol.37, pp.8901-8907, 2016
Ercelep O., Topcu T., Bayoglu I., Ekinci A., Koca S., Kavgaci H., et al., "Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.", TUMOR BIOLOGY, vol.37, pp.12033-12038, 2016
Yıldırım M., Kefeli U., Aydin D., Sener N., Gümüş M. , "The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker.", TUMOR BIOLOGY, vol.37, pp.11903-11907, 2016
Aydin D., Sendur M., Kefeli U., Ustaalioglu B., Aydin O., Yildirim E., et al.,"Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma.", CLINICAL COLORECTAL CANCER, vol.-, 2016
Aydin D., Sendur M., Kefeli U., Unal O., Tastekin D., Akyol M., et al.,"Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.", CLINICAL COLORECTAL CANCER, vol.-, 2016
Aydin D., Ali S.M., Kefeli U., Umut U.O., Tastekin D., Akyol M., et al., "Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).", JOURNAL OF BUON, vol.21, pp.1242-1249, 2016
Gunes-Bayir A., Kiziltan H., Sentürk N., Mayadagli A., Gümüş M. , "A Pilot Study of Self-Reported Physical Activity and Eating Habits in Turkish Cancer Patients Under Chemotherapy.", NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, vol.67, pp.906-11, 2015
Bilici A., Ozturk T., Turkmen E., Odabas H., Cihan S., Selcukbiricik F., et al., "Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.", WORLD JOURNAL OF UROLOGY, vol.33, pp.1613-22, 2015
Odabas H., Ulas A., Aydın K., Inanc M., Aksoy A., Yazilitas D., et al., "Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology.", TUMOR BIOLOGY, vol.36, pp.9641-8, 2015
Bilici A., Sonkaya A., Ercan S., Ustaalioglu B., Seker M., Aliustaoglu M., et al., "The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?", TUMOR BIOLOGY, vol.36, pp.823-8, 2015
Kafadar D., Ince N., Akcakaya A., Gümüş M. , "Evaluation of Managerial Needs for Palliative Care Centers: Perspectives of Medical Directors.", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.16, pp.4653-8, 2015
Benekli M., Altundag K., Dumanli E., Isikdogan A., Karaoglu A., Tekin S.B., et al.,"Association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.", JOURNAL OF CLINICAL ONCOLOGY, vol.33, 2015
Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.,"Treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology", WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.18, pp.273-278, 2014
Gumusay O., Coskun U., Akman T., Ekinci A.S., Kocar M., Erceleb O.B., et al., "Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, pp.151-157, 2014
Yalcin S., Gümüş M. , Kilickap S., Alkis N., Ilhan M., Oksuzoglu B., et al., "End-of-study results of Turkish gastric cancer patients from the global REGATE study", JOURNAL OF BUON, vol.19, pp.377-387, 2014
Bilici A., Inanc M., Ulas A., Akman T., Seker M., Babacan N., et al., "Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.6493-9, 2014
Mayadagli A., Karabulut G.S., Bilici A., Fatih O.A., Kocak M., Ozkan A., et al., "Prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer.", JOURNAL OF BUON, vol.19, pp.157-63, 2014
Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al., "Treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology", WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.18, pp.273-278, 2014
Oven U.B., Bilici A., Yilmaz B., Aliustaoglu M., Seker M., Vardar F., et al., "Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey.", BREAST CARE, vol.9, pp.123-7, 2014
Turan N., Benekli M., Dane F., Unal O., Kara H., Koca D., et al., "Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.", THORACIC CANCER, vol.5, pp.398-404, 2014
Cetin B., Benekli M., Dane F., Boruban C., Gümüş M. , Oksuzoglu B., et al., "Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience", BREAST CARE, vol.8, pp.67-70, 2013
Seker M., Sevinc A., Yildiz R., Cihan S., Kaplan M.A., Gokdurnali A., et al., "Prognostic Factors in Gastrointestinal Stromal Tumors: Multicenter Experience of 333 Cases from Turkey", HEPATO-GASTROENTEROLOGY, vol.60, pp.768-775, 2013
Korkmaz T., Seber S., Yavuzer D., Gümüş M. , Turhal N.S., "Primary renal carcinoid: Treatment and prognosis", CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol.87, pp.256-264, 2013
Uygun K., Bilici A., Kaya S., Ustaalioglu B.B.O., Yildiz R., Temiz S., et al., "Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.2283-2288, 2013
Alici S., Buyukberber S., Alkis N., Benekli M., Ozkan M., Bilici A., et al., "Low-Dose Docetaxel/Cisplatin - Leucovorin and 46 Hour Infusional Fluorouracil in Metastatic Gastric Carcinoma", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.423-427, 2013 (Group Author(s): Anatolian Soc Med Oncology )
Yetisyigit T., Arpaci E., Seber E.S., Kucukoner M., Kos F.T., Sonmez O.U., et al., "Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.5185-5188, 2013
Bilici A., Salman T., Ustaalioglu B.B.O., Unek T., Seker M., Aliustaoglu M., et al., "The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy", JOURNAL OF SURGICAL RESEARCH, vol.180, pp.E1-E9, 2013
Kaplan M.A., Isikdogan A., Gümüş M. , Arslan U.Y., Geredeli C., Ozdemir N., et al., "Childhood, Adolescents, and Young Adults (<= 25 y) Colorectal Cancer: Study of Anatolian Society of Medical Oncology", JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, vol.35, pp.83-89, 2013
Kefeli U., Buyukberber S., Akyol M., Yildiz R., Kaplan M.A., Ciltas A., et al., "Efficacy of Sunitinib in Turkish Patients with Gastrointestinal Stromal Tumors; Retrospective Multicenter Experience", HEPATO-GASTROENTEROLOGY, vol.60, pp.647-652, 2013 (Group Author(s): Anatolian Soc Med Oncology ASMO )
Kefeli U., Benekli M., Sevinc A., Yildiz R., Kaplan M.A., Ciltas A., et al., "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience", ONCOLOGY LETTERS, vol.6, pp.605-611, 2013
Tonyali O., Coskun U., Sener N., Inanc M., Akman T., Ulas A., et al., "Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab", ONKOLOGIE, vol.36, pp.554-558, 2013 (Group Author(s): ASMO )
Berk V., Kaplan M.A., Tonyali O., Buyukberber S., Balakan O., Ozkan M., et al., "Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.7367-7369, 2013
Ustaalioglu B.B.O., Ulas A., Esbah O., Turan N., Bilici A., Demirci U., et al., "Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey", THORACIC CANCER, vol.4, pp.161-166, 2013 (Group Author(s): ASMO )
Korkmaz T., Seber S., Kefeli U., Sari E., Canhoroz M., Oven B., et al., "Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.15, pp.535-540, 2013
Ustaalioglu B.B.O., Bilici A., Ercan S., Seker M., Orcun A., Gümüş M. , "The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer", MEDICAL ONCOLOGY, vol.30, 2013
Ustaalioglu B.B.O., Unal O.U., Turan N., Bilici A., Kaya S., Eren T., et al., "Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.6287-6292, 2013
Ustaalioglu B.O., Bilici A., Kefeli U., Seker M., Oncel M., Gezen C., et al., "The Importance of Multifocal/Multicentric Tumor on the Disease-Free Survival of Breast Cancer Patients Single Center Experience", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.35, pp.580-586, 2012
Bilici A., Yapici H.S., Ercan S., Seker M., Ustaalioglu B.B.O., Salman T., et al., "The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?", JOURNAL OF BUON, vol.17, pp.502-507, 2012
Gümüş M. , Davidson N., Bauknecht T., Soldatenkova V., Benhadji K.A., "Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study", CURRENT MEDICAL RESEARCH AND OPINION, vol.28, pp.401-413, 2012
Arslan U.Y., Oksuzoglu B., Ozdemir N., Aksoy S., Alkis N., Gok A., et al., "Outcome of non-metastatic male breast cancer: 118 patients", MEDICAL ONCOLOGY, vol.29, pp.554-560, 2012
Bilici A., Ustaalioglu B.B.O., Yavuzer D., Seker M., Mayadagli A., Gümüş M. , "Prognostic Significance of High Phosphatase of Regenerating Liver-3 Expression in Patients with Gastric Cancer Who Underwent Curative Gastrectomy", DIGESTIVE DISEASES AND SCIENCES, vol.57, pp.1568-1575, 2012
Ustaalioglu B.O., Bilici A., Ercan S., Orcun A., Seker M., Ozkan A., et al., "Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, pp.356-361, 2012
Inal A., Kos F.T., Algin E., Yildiz R., Dikiltas M., Unek I.T., et al., "Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study", NEOPLASMA, vol.59, pp.297-301, 2012
Kefeli U., Yildirim M.E., Aydin D., Madenci O.C., Yasar N., Sener N., et al., "Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment", BIOMARKERS, vol.17, pp.663-667, 2012
Tonyali O., Coskun U., Sener N., Inanc M., Akman T., Oksuzoglu B., et al., "Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.138, pp.2145-2151, 2012 (Group Author(s): ASMO )
Ustaalioglu B.B.O., Bilici A., Barisik N.O., Aliustaoglu M., Vardar F.A., Yilmaz B.E., et al., "Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, pp.911-922, 2012
Bilici A., Seker M., Oven Ustaalioglu B.B., Hallac Keser S., Cinaral F., Gümüş M. , "Gallbladder metastasis secondary to gastric cancer as a first site of recurrence presented with acute cholecystitis: Case report and literature review", TURKISH JOURNAL OF GASTROENTEROLOGY, vol.23, pp.764-768, 2012
Kaya A.O., Coskun U., Ozkan M., Sevinc A., Yilmaz A.U., Gümüş M. , et al., "Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy", ONKOLOGIE, vol.35, pp.576-580, 2012 (Group Author(s): ASMO )
Eser M., Kement M., Balin S., Coskun C., Kefeli U., Gümüş M. , et al., "Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer", WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012
Kaya A.O., Coskun U., Gümüş M. , Dane F., Ozkan M., Isikdogan A., et al., "The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens", JOURNAL OF CHEMOTHERAPY, vol.24, pp.217-220, 2012 (Group Author(s): ASMO )
Mayadagli A., Kocak M., Demir O., Gul S.K., Ozkan A., Parlak C., et al., "Elective bladder preservation with multimodality treatment for bladder cancer", JOURNAL OF BUON, vol.17, pp.483-489, 2012
Inal A., Kos F.T., Algin E., Yildiz R., Berk V., Unek I.T., et al., "Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study", JOURNAL OF BUON, vol.17, pp.102-105, 2012 (Group Author(s): Anatolian Soc Med Oncology )
Gezen C., Kement M., Altuntas Y.E., Okkabaz N., Seker M., Vural S., et al., "Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors", WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012
Altinbas M., Kalender M.E., Oven B., Sevinc A., Karaca H., Kaplan M.A., et al., "Weekly Topotecan for Recurrent Small Cell Lung Cancer - a Retrospective Anatolian Medical Oncology Group Study", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, pp.2909-2912, 2012
Bilici A., Ustaalioglu B.B.O., Ercan S., Seker M., Yilmaz B.E., Orcun A., et al., "The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer", TUMOR BIOLOGY, vol.33, pp.2201-2208, 2012
Ozkan M., Berk V., Kaplan M.A., Benekli M., Coskun U., Bilici A., et al., "Gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience", NEOPLASMA, vol.59, pp.38-42, 2012
Inal A., Ciltas A., Yildiz R., Berk V., Kos F.T., Dane F., et al., "Long Term Survivors with Metastatic Pancreatic Cancer Treated with Gemcitabine Alone or Plus Cisplatin: a Retrospective Analysis of an Anatolian Society of Medical Oncology Multicenter Study", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, pp.1841-1844, 2012
Bilici A., Dane F., Seker M., Ustaalioglu B.B.O., Aliustaoglu M., Temiz S., et al., "Is Subdivision of pT2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers", DIGESTIVE DISEASES AND SCIENCES, vol.56, pp.3226-3234, 2011
Alkis N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., et al., "Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure", JOURNAL OF BUON, vol.16, pp.80-83, 2011 (Group Author(s): Anatolian Soc Med Oncology ASMO )
Barisik N.O., Keser S.H., Gul A.E., Sensu S., Kandemir N.O., Küçük H.F., et al., "The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast", MEDICAL ONCOLOGY, vol.28, pp.703-708, 2011
Kefeli U., Kaya S., Ustaalioglu B.O., Bilici A., Kefeli A.U., Yildirim M.E., et al., "Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience", MEDICAL ONCOLOGY, vol.28, pp.661-666, 2011
Kefeli U., Bilici A., Ustaalioglu B.B.O., Kefeli A.U., Yildirim M.E., Seker M., et al., "A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.283, pp.405-407, 2011
Ustaalioglu B.B.O., Seker M., Bilici A., Canpolat N., Yildirim E., Kefeli U., et al., "The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma", MEDICAL ONCOLOGY, vol.28, pp.258-264, 2011
Bilici A., Ustaalioglu B.B.O., Ercan S., Orcun A., Seker M., Salepçi T., et al., "Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?", CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.68, pp.309-316, 2011
Seker M., Bilici A., Ustaalioglu B.O., Yilmaz B., Ozturk B., Unal A., et al., "Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.284, pp.405-409, 2011
Basaran G., Turhal N.S., Cabuk D., Yurt N., Yurtseven G., Gümüş M. , et al., "Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey", MEDICAL ONCOLOGY, vol.28, pp.409-415, 2011
Sevinc A., Seker M., Bilici A., Ozdemir N.Y., Yildiz R., Ustaalioglu B.O., et al., "Co-existence of Gastrointestinal Stromal Tumors with Other Primary Neoplasms", HEPATO-GASTROENTEROLOGY, vol.58, pp.824-830, 2011
Sonmez B., Seker M., Bilici A., Erkal F.Y., Ustaalioglu B.B.O., Gümüş M. , et al., "Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer?", JOURNAL OF BUON, vol.16, pp.227-232, 2011
Bilici A., Ustaalioglu B.B.O., Seker M., Kefeli U., Canpolat N., Tekinsoy B., et al., "The role of F-18-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.38, pp.64-73, 2011
Mayadagli A., Aksu A., Goksel F., Gocen E., Karahacioglu E., Gümüş M. , et al., "DETERMINATION OF PARAMETERS AFFECTING THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IN CANCER PATIENTS AND DETECTION OF PREVALENCE OF USE", AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, vol.8, pp.477-482, 2011
Seker M., Bilici A., Guler D.O., Ustaalioglu B.B., Gozu H., Erkal F.Y., et al., "Tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?", HEPATO-GASTROENTEROLOGY, vol.58, pp.1841-1846, 2011
Ustaalioglu B.B.O., Bilici A., Kefeli U., Seker M., Salepci T., Unal O., et al., "A retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience", JOURNAL OF BUON, vol.16, pp.349-352, 2011
Bilici A., Seker M., Ustaalioglu B.B.O., Canpolat N., Salepçi T., Gümüş M. , "Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images", JOURNAL OF KOREAN MEDICAL SCIENCE, vol.26, pp.574-576, 2011
Dane F., Ozturk M.A., Gümüş M. , Guven A., Aliustaoglu M., Cabuk D., et al., "Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study", JOURNAL OF BUON, vol.16, pp.257-264, 2011
Gezen C., Altuntas Y.E., Kement M., Okkabaz N., Bilici A., Vural S., et al., "Laparoscopic Abdominoperineal Resections for Mid or Low Rectal Adenocarcinomas: A Retrospective, Comparative Study", SURGICAL LAPAROSCOPY ENDOSCOPY TECHNIQUES, vol.21, pp.396-402, 2011
Seker M., Ozdemir B., Bilici A., Ustaalioglu B.B., Sönmez B., Yilmaz B.E., et al., "Bilateral Conjunctival MALT Lymphoma Mimicking Chronic Conjunctivitis", ONKOLOGIE, vol.33, pp.317-320, 2010
Yildiz R., Kalender M., Dane F., Sevinc A., Gümüş M. , Camci C., et al., "Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.", JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.16, pp.173-8, 2010
Bilici A., Ustaalioglu B.B.O., Gümüş M. , Seker M., Yilmaz B., Kefeli U., et al., "Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?", ONKOLOGIE, vol.33, pp.101-105, 2010
Karagoz B., Bilgi O., Gümüş M. , Erikci A.A., Sayan O., Turken O., et al., "CD8+CD28-cells and CD4+CD25+regulatory T cells in the peripheral blood of advanced stage lung cancer patients", MEDICAL ONCOLOGY, vol.27, pp.29-33, 2010
Aliustaoglu M., Bilici A., Ustaalioglu B.B.O., Konya V., Gucun M., Seker M., et al., "The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment", MEDICAL ONCOLOGY, vol.27, pp.1060-1065, 2010
Yumuk P.F., Kefeli U., Ceyhan B., Dane F., Eroglu B.T., Gümüş M. , et al., "Pulmonary toxicity in patients receiving docetaxel chemotherapy", MEDICAL ONCOLOGY, vol.27, pp.1381-1388, 2010
Bilici A., Bilici A., Ustaalioglu B.B.O., Seker M., Canpolat N., Gümüş M. , "F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome", CLINICAL NUCLEAR MEDICINE, vol.35, pp.211-212, 2010
Bilici A., Seker M., Ustaalioglu B.B.O., Kefeli U., Yildirim E., Yavuzer D., et al., "Prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection", ANNALS OF SURGICAL ONCOLOGY, vol.17, pp.2037-2044, 2010
Bilici A., Seker M., Ustaalioglu B.B.O., Yilmaz B., Doventas A., Salepçi T., et al., "Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer", MEDICAL ONCOLOGY, vol.27, pp.975-984, 2010
Ustaalioglu B.B.O., Gümüş M. , Bilici A., Seker M., Ustaalioglu R., Kefeli U., et al., "Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience", JOURNAL OF BUON, vol.15, pp.529-536, 2010
Bilici A., Ustaalioglu B.B.O., Seker M., Canpolat N., Tekinsoy B., Salepçi T., et al., "Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.37, pp.1259-1269, 2010
Seker M., Ustaalioglu B.B.O., Bilici A., Yildirim M.E., Kefeli U., Barisik N.O., et al., "Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma", LEUKEMIA RESEARCH, vol.34, pp.E160-E163, 2010
Ustaalioglu B.B.O., Gümüş M. , Unal A., Cayir K., Sever O., Bilici A., et al., "Malignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases) Multicenter Experiences", INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.20, pp.698-703, 2010
Aliustaoglu M., Bilici A., Gümüş M. , Colak A.T., Baloglu G., Irmak R., et al., "Preoperative serum leptin levels in patients with breast cancer", MEDICAL ONCOLOGY, vol.27, pp.388-391, 2010
Ustaalioglu B.B.O., Gümüş M. , Bilici A., Seker M., Dane F., Salepçi T., et al., "Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience", MEDICAL ONCOLOGY, vol.27, pp.454-458, 2010
Kaya A.O., Buyukberber S., Dane F., Isikdogan A., Ustaalioglu B.O., Coskun U., et al., "Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer", TUMORI, vol.96, pp.400-404, 2010 (Group Author(s): ASMO )
Aliustaoglu M., Bilici A., Seker M., Dane F., Gocun M., Konya V., et al., "The Association of Pre-treatment Peripheral Blood Markers with Survival in Patients with Pancreatic Cancer", HEPATO-GASTROENTEROLOGY, vol.57, pp.640-645, 2010
Sezen O.S., Eraslan G., Coskuner T., Yavuzer D., Bilici A., Bilge S., et al., "Endometrial Adenocarcinoma Metastasis to Nasal Skin", JOURNAL OF OTOLARYNGOLOGY-HEAD SURGERY, vol.39, pp.E8-E11, 2010
Barisik N.O., Bozkurt S., Gümüş M. , Kaygusuz I., Karadayi N., Bas E., et al., "Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study", DIAGNOSTIC PATHOLOGY, vol.5, 2010
Gümüş M. , Ustaalioglu B.O., Garip M., Kiziltan E., Bilici A., Seker M., et al., "Factors that Affect Patients' Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients", BREAST CARE, vol.5, pp.164-168, 2010
Seker M., Bilici A., Sönmez B., Ustaalioglu B.B.O., Gümüş M. , Gozu H., et al., "The association of serum adiponectin levels with histopathological variables in gastric cancer patients", MEDICAL ONCOLOGY, vol.27, pp.1319-1323, 2010
Bilici A., Salepçi T., Dane F., Gümüş M. , Ustaalioglu B.B.O., Seker M., et al., "Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.282, pp.417-425, 2010
Salepçi T., Seker M., Uyarel H., Gümüş M. , Bilici A., Ustaalioglu B.B.O., et al., "5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels", MEDICAL ONCOLOGY, vol.27, pp.416-420, 2010
Ustaalioglu B.B.O., Bilici A., Seker M., Canpolat N., Ozdemir N., Salepçi T., et al., "Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: Positron emission tomography images before and after therapy: A case report", LEUKEMIA RESEARCH, vol.34, pp.E108-E110, 2010
Bilici A., Uygun K., Seker M., Ustaalioglu B.B.O., Aliustaoglu M., Temiz S., et al., "The Effect of Tumor Size on Overall Survival in Patients with pT3 Gastric Cancer: Experiences from 3 Centers", ONKOLOGIE, vol.33, pp.676-682, 2010
Ustaalioglu B.B.O., Bilici A., Kefeli U., Seker M., Yildirim E., Salepçi T., et al., "Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences", ONCOLOGY, vol.79, pp.105-111, 2010
Salman T., Seker M., Bilici A., Ustaalioglu B.B., Gümüş M. , Yaylaci M., "Lung cancer presenting with extreme leukocytosis", JOURNAL OF BUON, vol.15, pp.193-193, 2010
Oven B.B.U., Bilici A., Seker M., Salepci T., Keser S., Gümüş M. , "Renal cell carcinoma with pulmonary metastasis misdiagnosed as other primary malignant tumor", JOURNAL OF BUON, vol.14, pp.727-728, 2009
Seker M., Ustaalioglu B.B., Bilici A., Ozseker N.I., Aksu A., Gümüş M. , "Acute renal failure and multiple extranodal involvement in a patient with diffuse large B cell lymphoma", JOURNAL OF BUON, vol.14, pp.726-727, 2009
Kocak M., Ozkan A., Mayadagli A., Parlak C., Bilici A., Bilici A., et al., "Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: A single-institution review of two different regimens", CLINICAL LUNG CANCER, vol.10, pp.124-129, 2009
Alici S., Coskun U., Alkış N., Sevinc A., Dane F., Gümüş M. , et al., "Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.10, pp.1051-1056, 2009
Karaoglu A., Arslan U.Y., Ozkan M., Kalender M.E., Alici S., Coskun U., et al., "Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.10, pp.63-66, 2009 (Group Author(s): Anatolian Soc Med Oncology )
Ustaalioglu B.B.O., Bilici A., Seker M., Salman T., Gümüş M. , Barisik N.O., et al., "Metastasis of Lobular Breast Carcinoma to the Uterus in a Patient under Anastrozole Therapy", ONKOLOGIE, vol.32, pp.424-426, 2009
Salepci T., Seker M., Kurnaz E., Guler D., Bilici A., Dane F., et al., "Conjunctival malt lymphoma successfully treated with single agent rituximab therapy", LEUKEMIA RESEARCH, vol.33, pp.1-1, 2009
Demirhan R., Mayadagli A., Parlak C., Kocak M., Ozkan A., Gümüş M. , "Our resection outcome in lung cancer: Evaluation of 45 consequential patients", JOURNAL OF CLINICAL ONCOLOGY, vol.26, 2008
Kaya A.O., Coskun U., Unlu M., Akdemir U.O., Ozdemir N.Y., Zengin N., et al., "Whole Body 18F-FDG PET/CT Imaging in the Detection of Primary Tumours in Patients with a Metastatic Carcinoma of Unknown Origin", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.9, pp.683-686, 2008 (Group Author(s): Anatolian Soc Med Oncology )
Bilgi O., Karagoz B., Turken O., Kandemir E.G., Ozturk A., Gümüş M. , et al., "Peripheral blood gamma-delta T cells in advanced-stage cancer patients", ADVANCES IN THERAPY, vol.25, pp.218-224, 2008
Koldas M., Gümüş M. , Seker M., Seval H., Karaoglu H., Dane F., et al., "Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer", CLINICAL LUNG CANCER, vol.9, pp.112-115, 2008
Kocak M., Mayadagli A., Ozkan A., Parlak C., Demir O., Marti A., et al., "Outcome of metastatic non-small cell lung carcinoma patients receiving docetaxel-cisplatin combination chemotherapy: single institution experience", JOURNAL OF BUON, vol.12, pp.471-476, 2007
Sakar B., Gümüş M. , Basaran M., Argon A., Ustuner Z., Ustaoglu M.A., et al., "XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer", ONCOLOGY, vol.73, pp.298-304, 2007
Gümüş M. , Yumuk P.F., Salepci T., Aliustaoglu M., Dane F., Ekenel M., et al., "HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples", JOURNAL OF EXPERIMENTAL CANCER RESEARCH, vol.25, pp.515-521, 2006
Gümüş M. , Yumuk P., Atalay G., Aliustaoglu M., Macunluoglu B., Dane F., et al., "What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery?", TUMORI, vol.91, pp.168-172, 2005
Yumuk P., Abacioglu U., Demir G., Cabuk D., Dane F., Gümüş M. , et al., "Does the incidence of anal canal cancers differ in Moslem societies?", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.20, pp.76-76, 2005
Yumuk P., Turhal N., Gümüş M. , Hatabay N., Turken O., Ozkan A., et al., "Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer", BMC CANCER, vol.5, 2005
Turhal N., Dane F., Dede F., Gümüş M. , Yumuk P., Cakalagaoglu F., et al., "99m-Tc-MDP-scintimammography in the evaluation of breast masses or tumor angiogenesis", ANTICANCER RESEARCH, vol.24, pp.1999-2006, 2004
Aliustaoglu M., Yumuk P., Gümüş M. , Ekenel M., Bolukbas F., Bolukbas C., et al., "D-dimer - Can it be a marker for malignant gastric lesions?", ACTA ONCOLOGICA, vol.43, pp.770-771, 2004
Yumuk P., Aydin S., Dane F., Gümüş M. , Ekenel M., Aliustaoglu M., et al., "The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.19, pp.609-610, 2004
Bolukbas F., Kilic H., Bolukbas C., Gümüş M. , Horoz M., Turhal N., et al., "Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study", BMC CANCER, vol.4, 2004
Sakar B., Karagol H., Gümüş M. , Basaran M., Kaytan E., Argon A., et al., "Timing of death from tumor recurrence after curative gastrectomy for gastric cancer", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.27, pp.205-209, 2004
Yumuk P., Gümüş M. , Ekenel M., Basaran G., Aliustaoglu M., Topal A., et al., "Attitude toward genetic testing for cancer risk in Istanbul", GENETIC TESTING, vol.8, pp.169-173, 2004
Bolukbas F., Bolukbas C., Horoz M., Gümüş M. , Erdogan M., Zeyrek F., et al., "Child-Pugh classification dependent alterations in serum leptin levels among cirrhotic patients: a case controlled study", BMC GASTROENTEROLOGY, vol.4, 2004
Yumuk P., Abacioglu U., Caglar H., Gümüş M. , Sengoz M., Turhal N., "Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in marmara university hospital", JOURNAL OF CHEMOTHERAPY, vol.15, pp.603-606, 2003
Turhal N.S., Aliustaoglu M., Gurses A., Gümüş M. , Atalay G., Karamanoglu A., et al., "Neoplastic diseases prevalence in a turkish university hospital", JOURNAL OF BUON, vol.8, pp.45-48, 2003
Turk-Boru U., Kocer A., Alp R., Gumus M., Gümüş M. , "Status epilepticus in a case of Wilson's disease during D-pencillamine treatment", SWISS MEDICAL WEEKLY, vol.133, pp.446-447, 2003
Turhal N., Efe B., Gümüş M. , Aliustaoglu M., Karamanoglu A., Sengoz M., "Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey.", BMC CANCER, vol.2, pp.30-30, 2002
Turhal N.S., Gümüş M. , Atalay G., Aliustaoglu M., Kabakas F., Karamanoglu A., et al., "Outpatient cancer care in a Turkish University hospital", JOURNAL OF BUON, vol.7, pp.397-398, 2002
Diger Dergilerde Yayımlanan Makaleler
Yanik A. , Gümüş M. , "The Tendency for Social Phobic Anxiety and Avoidance in University Students ", International Refereed Journal of Humanities and Academic Sciences, vol.19, pp.25-49, 2017 (Link)
Ozmen V., Dagoglu N., Dede I., Akcakaya A., Kerem M., Goksel F., et al., "Turkish Ministry of Health, 2nd Turkish Medical General Assembly Clinical Oncology Study Group Report", JOURNAL OF BREAST HEALTH, vol.12, pp.9-17, 2016
Kefeli U., Ustaalioglu B.B.O., Yilmaz B., Aydin D., Sener N., Aliustaoglu M., et al., "Non-Small Cell Lung Cancer in Women: A Distinct Entity?", Gazi Medical Journal, cilt.25, ss.92-96, 2014 (Link)
Gül Ş.K., Mayadağli A., Gümüş M. , "Akciğer Kanserli Geriatrik Hastalarda Tedavi Yaklaşımı Treatment Approach for Lung Cancer of Geriatric Patients", J Kartal TR, cilt.25, ss.257-260, 2014 (Link)
Aydin K., Gümüş M. , "İleri Evre Gastroenteropankreatik Nöroendokrin Tümörlerin Tedavisinde Sunitinib'in Yeri", Turkiye Klinikleri Journal of Medical Oncology Special Topics, cilt.6, ss.57-60, 2013
Bilici A., Ustaalioglu B.B.O., Seker M., Gümüş M. , Ünal O., "Clinicopathological features in patients with rare ovarian cancers", Türk Onkoloji Dergisi, cilt.27, ss.001-009, 2012 (Link)
Ustaalioglu B.B.O., Bilici A., Seker M., Salepci T., Ustaalioğlu R., Cömert S., et al., "The Relationship between Prognostic Factors and Overall Survival in Small Cell Lung Cancer Patients: a Single Centre Experience", Türk Toraks Dergisi, cilt.13, ss.60-64, 2012 (Link)
Mayadağli A., Ekici K., Kökten Ş., Gümüş M. , "Memenin Primer Skuamöz Hücreli Karsinomu: Olgu Sunumu ve Literatürün Gözden Geçirilmesi", Okmeydanı Tıp Dergisi, cilt.28, ss.112-114, 2012 (Link)
Ekici K., Mayadagli A., Korkmaz T., Barisik N., Gümüş M. , "Sarcomatoid carcinoma of the small intestine: a case report and review of the literature", Case Study and Case Report, vol.2, pp.74-80, 2012 (Link)
Gümüş M. , "Epidemiology and Etiology in Gastric Cancer", Turkiye Klinikleri Journal of Medical Oncology Special Topics Issue, cilt.5, ss.1-5, 2012
Ustaalioğlu B.B., Ustaalioğlu R., Bilici A., Doğusoy I., Barişik N.Ö., Gümüş M. , "GÖĞÜS DUVARINA METASTAZ YAPAN VE CERRAHİ UYGULANAN RENAL PELVİS KARSİNOMA OLGUSU", Acta Oncologica Turcica, cilt.44, ss.36-41, 2011
Şeker M., Mengi A., Bilici A., Ustaalioğlu B.B., Kefeli U., Özşeker N.I., et al., "Evaluation of Hodgkin lymphoma cases and determination of prognostic factors/Hodgkin lenfoma olgularinin retrospektif degerlendirilmesive prognostik faktorlerin saptanmasi", Turkish Journal of Oncology, cilt.26, ss.108-114, 2011 (Link)
Gümüş M. , "Antijen Temelli Aşılar", Turkiye Klinikleri J Med Oncol-Special Topics, cilt.3, ss.77-82, 2010
Bilici A., Seker M., Ustaalioglu B.B.O., Dane F., Aliustaoglu M., Erkol B., et al., "Lenf Nodu Negatif Mide Kanserli Hastalarda Sağkalım Üzerine EtkiliPrognostik Faktörlerin Değerlendirilmesi: Üç Merkez Deneyimi", Türk Onkoloji Dergisi, cilt.25, ss.135-142, 2010
Bilici A., Seker M., Ustaalioglu B.B.O., Salman T., Salepci T., Yavuzer D., et al., "A Case of Recurrent Breast Cancer Diagnosed vvith Isolated Ovarian Metastasis Under Anastrazole Therapy ", Acta Oncologica Turcica, cilt.43, ss.42-45, 2010 (Link)
Aliustaoglu M., Ustaalioglu B.B.O., Bilici A., Konya V., Gücün M., Seker M., et al., "Is the Complete Blood Count Parameters Predict Prognosis Before Treatment in Metastatic Gastric Cancer Patients? ", Acta Oncologica Turcica, cilt.43, ss.13-18, 2010 (Link)
Bilici A., Gümüş M. , "Kapesitabin: Kolorektal Kanserlerde Kullanımı", Remisyon, cilt.10, ss.11-16, 2010
Ustaalioglu B.B.O., Bilici A., Seker M., Salepci T., Yildirim E., Kefeli U., et al., "İnflamatuvar Meme Kanseri Serimiz: Tek Merkez Deneyimi ", Acta Oncologica Turcica, cilt.42, ss.93-99, 2009 (Link)
Ustaalioglu B., Seker M., Bilici A., Erkol B., Kefeli U., Yildirim E., et al., "NADİR BİR NAZOLAKRİMAL HEMANJİYOPERİSTOM OLGUSU", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.19, ss.93-96, 2008 (Link)
Demirhan R., Öz K., Çağan P., Dabak R., Mayadağli A., Gümüş M. , "Mediastinal Dev Schwannoma", Akciğer, cilt.13, ss.95-98, 2007
Demirhan R., Mayadağli A., Sancakli İ., Özdemir N., Gümüş M. , Parlak C., et al., "AKCİĞER KANSERLERİNDE REZEKSİYON SONUÇLARIMIZ: ARDIŞIK 45 HASTANIN DEĞERLENDİRİLMESİ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.17, ss.82-88, 2006 (Link)
Karaoğlu H., Gümüş M. , Sargin H., Koç Y., Güler Ş., Colak A.T., et al., "HODGKiN DIŞI LENFOMALI HASTALARıN KLiNiK ÖZELLiKLERiNiN VE TEDAVi SONUÇLARININ DEGERLENDiRiLMESi ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.15, ss.8-10, 2004
Yumuk F., İyikesici S., Gümüş M. , Aliustaoglu M., Dane F., Basaran G., et al., "Lokal ‹leri ve Metastatik Küçük Hücreli D›fl› Akci¤er Kanseri Hastalar›n›n De¤erlendirilmesi Marmara Üniversitesi Deneyimi", Türk Onkoloji Dergisi, cilt.19, ss.106-111, 2004 (Link)
Basaran G., Ekenel M., Demirkalem P., Çakır T., Güllüoğlu B., Gümüş M. , et al., "Evre I (T1N0M0) Meme Kanseri: Patolojik Özellikler ve Klinik Sonuçlar", Türk Onkoloji Dergisi, cilt.19, ss.53-57, 2004 (Link)
Yıldız G., Sargin M., Sargin H., Gümüş M. , Yayla A., "İmidazolin Reseptör Agonisti Rilmenidinin, Metabolik Sendrom X Olgularında Klinik, Metabolik ve Endokrin Parametrelere Etkisi.", Diabet Bilimi, cilt.1, ss.71-76, 2003
Ramazanoğlu D.T., Gümüş M. , Koç Y., Şeker M., Sargin H., Tekçe M., et al., "AKUT MYOKARD İNFARKTÜSÜ GEÇİREN ERKEK HASTALARDA SERUM ÖSTRADİOL, TESTOSTERON VE NOREPİNEFRİN DÜZEYLERİ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.14, ss.159-163, 2003 (Link)
Sever Ö.N., Gümüş M. , Sargin H., Koç Y., Salepçi T., Yayla A., "MALİGN MEZOTELYOMA VAKALARINDA YÜKSEK DOZ METOTREKSAT UYGULAMASININ ETKİNLİĞİ", Kartal E¤itim ve Araflt›rma Hastanesi T›p Dergisi, cilt.14, ss.20-22, 2003
Koç Y., Sargin H., Gemici C., Bolukbas F., Gümüş M. , Tekçe M., et al., "PANKREAS KARS‹NOMLU OLGULARIN DE⁄ERLEND‹R‹LMES‹", Kartal E¤itim ve Araflt›rma Hastanesi T›p Dergisi, cilt.14, ss.146-148, 2003 (Link)
Karamanoglu A., Yumuk P.F., Gümüş M. , Ekenel M., Aliustaoglu M., Selimen D., et al., "Port Needles: Do They Need to be Removed as Frequently in Infusional Chemotherapy?", Journal of Infusion Nursing, vol.26, pp.239-242, 2003
Erbay İ., Gümüş M. , Sargin H., Fenercioğlu S., Sargin M., Seker M., et al., "Akut Myokard İnfarktüsünde Mikroalbuminüri ve Trombolitik Tedavinin Mikroalbuminüri Düzeylerine Etkisi", Şişli Etfal Hastanesi Tıp Bülteni , cilt.36, ss.43-48, 2002
Biriz N., Gümüş M. , Sargın M., Emre B., Koç Y., Aliustaoglu M., et al., "DiYABETiK HASTALARDA KARACiGER YAGLANMASI VE y-GLUTAMiL TRANSPEPTiDAZ DÜZEYLERi ", Kartal Eğitim ve Araştırma Tıp Dergisi, cilt.12, ss.1-4, 2001 (Link)
Türk Ü.B., Sargin H., Alp R., Sargin M., Gümüş M. , Tekçe M., et al., "Ağrılı Diabetik Polinöropatide Vigabatrine Kullanımı", Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi , cilt.34, ss.8-12, 2001
Fenercioğlu S., Gümüş M. , Erbay İ., Sargin H., Sargin M., Aliustaoglu M., et al., "AKUT MYOKARD İNFARKTÜSÜNDE AKUT FAZ REAKTANLARINDAKİ DEGİşİM VE TROMBOLİTİK TEDAVİNİN BU DEGİşİME ETKİsİ ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.11, ss.865-869, 2000 (Link)
Gümüş M. , Urutürk O., Sargin M., Akin A., Koç Y., Aliustaoğlu M., et al., "Diyabet Süresi, HbA1c Düzeyleri ve Retinopati", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.11, ss.862-864, 2000 (Link)
Koç Y., Gümüş M. , Sargin M., Kavakli B., Yayla A., "ANTİHİPERTANSİF TEDAVİDE DOKSAZOsİN, AMLODİpİN VE RAMİpRiLİN KAN LİPID PROFİLİ VE KAN GLUKOZ DÜZEYİNE ETKİLERİNİN KARŞILAŞTIRILMASI ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.11, ss.817-819, 2000 (Link)
Aliustaoğlu M., Gümüş M. , Gökçel A., Özer T., Bican M., Özdil K., et al., "KRONİK BÖBREK YETMEZLİGİNDE HEMODİYALİZİN ATRİAL NATRİüRETİK PEPTİD DÜZEYLERİNE ETKİsİ ", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.10, ss.740-742, 1999 (Link)
Gümüş M. , Kavaklı B., Aktaş S., Sarğin M., Aliustaoglu M., Özdil K., et al., "ANJİOTENSİN II RESEPTÖR BLOKAJININ Tİp II DİABETES MELLİTUS'LU HASTALARDA KAN LİpİD DÜZEYLERİNE ETKİSi' ", KARTAL EĞİTİM ve ARAŞTIRMA KLİNİKLERİ, cilt.10, ss.752-757, 1999 (Link)
Kavakli B., Sarğin M., Gümüş M. , "DİABETES MELLİTUS'UN AKUT METABOLİK KOMPLİKASYONLARI - III: LAKTİK ASİDOZ ", Kartal Eğitim ve Araştırma Klinikleri, cilt.9, ss.718-719, 1998 (Link)
Yıldız G., Kavaklı B., Gümüş M. , Küçük H.F., Salepçi T., Sargın M., et al., "BİR İNSÜLİNOMA OLGUSU", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, cilt.1-4, ss.706-709, 1998 (Link)
Kavakli B., Sargin M., Gümüş M. , "DİABETES MELLİTUS'UN AKUT METABOLİK KOMPLİKASYONLARI - I :DİABETİK KETOASİDOZ ", Kartal Eğitim ve Araştırma Klinikleri, cilt.9, ss.710-713, 1998 (Link)
Kavakli B., Sargin M., Gümüş M. , "DiABETES MELLiTUS'UN AKUT METABOLiK KOMPLiKASYONLARI - II: HiPERGLiSEMiK HiPEROZMOLAR NONKETOTiK KOMA ", Kartal Eğitim Araştırma Klinikleri, cilt.9, ss.714-717, 1998 (Link)
Dolapcioğlu C., Kavakli B., Tuncer K., Kiliç D., Aktunç E., Gümüş M. , et al., "CUSHİNG SENDROMU İLE SEYREDEN BİR SÜRRENAL KARSİNOM OLGUSU ", KARTAL EĞİTİM veARAŞTIRMA KLİNİKLERİ, cilt.8, ss.656-659, 1997 (Link)
Kavakli B., Kiliç D., Gümüş M. , "TIP II DİABETTE BETA STİMÜLAN ORAL ANTİDİABETİK DROGLAR VE KULLANIM ENDİKASYONLARI ", Kartal Eğitim ve Araştırma Klinikleri, cilt.8, ss.661-665, 1997 (Link)
Hakemli Kongre/Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar
Yumuk R., Turhal N., Ahiskali R., Gümüş M. , Hatabay N., Turken O., et al., "P53 Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel", World Lung Congress, KANADA, - , vol.49, pp.S152-S152
Gümüş M. , Evrensel T., Göker E., Mandel N., Özdemir F., Öksüzoğlu B., et al., "The views and practice of oncologists on assessment of nutritional status and provision of nutritional care among cancer patients: A questionnaire-based survey.", ASPEN 2018, LAS VEGAS, ABD, 22-25 Ocak 2018, vol.0, no.0, pp.77-77
Şendoğan F., Uçar T., Turan T., Gümüş M. , Yildirim A., "BEP chemotherapy in non-seminomatous testis cancer with multiple liver metastasis: a case report", 8th Eurasian Uro-oncology Congress, 28 June – 1 July 2018, Tiflis, Gürcistan, Tiflis, GURCISTAN, 28 Haziran - 1 Temmuz 2018, pp.279-279
Paz-Ares L.G., Luft A., Tafreshi A., Gümüş M. , Mazieres J., Hermes B., "Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).", ASCO Annual Meeting, CHICAGO, ABD, 31 Mayıs - 5 Haziran 2018, vol.36, pp.1-1
Uçar T., Turan T., Toksöz Yıldırım A. , Gümüş M. , Çaşkurlu T., Yildirim A., "Retroperitoneal sarcomas with 3 cases", 8th Eurasian Uro-oncology Congress, 28 June – 1 July 2018, Tiflis, Gürcistan, Tiflis, GURCISTAN, 28 Haziran - 1 Temmuz 2018, pp.296-297
Gümüş M. , Geredeli C., Ucar M., Kaya S., Demir H., Unal O.U., et al., "EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.", ASCO 2017, CHICAGO, ABD, 30 Mayıs - 3 Haziran 2017, vol.35, pp.---
Çil Akinci A., Coşar Çetin F., Tuna R., Gümüş M. , "Anxiety And Depressıon In Cancer Dıseases", 2nd International Science Symposium-Science Festival, ISS2017, Tiflis, GURCISTAN, 5-8 Eylül 2017, pp.71-71
Bilici A., Gümüş M. , Malhan S., Oksuz E., Oksuzoglu B., Yalcm S., "ECONOMIC BURDEN OF GASTRIC CANCER IN TURKEY", ISPOR 20th Annual European Congress, GLASGOW, INGILTERE, 6-6 Kasım 2017, vol.20, pp.A429-A429
Kilickap S., Gümüş M. , Uncu D., Ozkan M., Cicin I., Elkiran T.E., et al., "Outcomes of Turkish National Breast Cancer Registry.", ASCO 2017, CHICAGO, ABD, 30 Mayıs - 3 Haziran 2017, vol.35, pp.---
Cicin I., Gümüş M. , Uncu D., Ozkan M., Kilickap S., Elkiran T.E., et al., "Characteristics of Turkish colorectal cancer patients and bevacizumab preference.", ASCO 2017, CHICAGO, ABD, 30 Mayıs - 3 Haziran 2017, vol.35, pp.---
Kilickap S., Altundag K., Dumanli E., Gümüş M. , Uslu R., Ozyilkan O., et al., "Geographic variations of clinical characteristics in breast cancer: Analysis of Turkish National Breast Cancer Registry.", ASCO Annual Meeting, CHICAGO, ABD, 1-7 Haziran 2015, vol.33, pp.1-1
Akgün Z., Güral Z., Süt P., Seker M., Mayadagli A., Turk H.M., et al., "LOKAL İLERİ PANKREAS KANSERİ TEDAVİSİNDE KAPESİTABİN BAZLI KEMOTERAPİ İLE HİPERFRAKSİYONE RADYOTERAPİNİN GÜVENİLİRLİĞİ-PİLOT ÇALIŞMA", 21.Ulusal Kanser Kongresi, ANTALYA, TÜRKIYE, 22-26 Nisan 2015, ss.522-522
Kaplan M.A., Urakci Z., Gümüş M. , Arslan U.Y., Geredeli C., Ozdemir N., et al., "What are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2015, vol.33, pp.1-1
Ciltas A., Karaca M., Uncu D., Ozkan M., Aliustaoglu M., Tekin S.B., et al., "Effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2015, vol.33, pp.1-1
Mutlu H.H., Mutlu H.H., Selek S., Mayadagli A., Turk H.M., Seker M., et al., "Metacognitive processes in cancer patients", ECCO-ESMO Congress, VİYANA, AVUSTURYA, 16-21 Ekim 2015, vol.51, pp.S218-S218
Celik I., Mandel N.M., Gokmen E., Unal O.U., Sevinc A., Coskun H.S., et al., "Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey", ASCO Annual Meeting, CHICAGO, ABD, 28 Mayıs - 5 Haziran 2015, vol.33, pp.1-1
Yuksel S., Kodaz H., Yildiz I., Odabasi H., Ocak A., Bayoglu I.V., et al., "Frequency of EGFR Mutation in Nsclc and Its Relationship with Clinicopathological Features: A Multicenter Asmo Trial", WORLD LUNG CONGRESS, DENVER, ABD, 1-5 Kasım 2015, vol.10, pp.S586-S586
Gümüş M. , Dane F., Karabulut B., Uygun K., Aydin K., Orhan B., et al., "Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2015, vol.33, pp.1-1 (Group Author(s): Turkras Study Grp )
Benekli M., Altundag K., Dumanli E., Isikdogan A., Karaoglu A., Tekin S.B., et al., "Association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2015, vol.33, pp.1-1
Altundag K., Dumanli E., Aliustaoglu M., Uncu D., Ozkan M., Cicin I., et al., "Turkish National Breast Cancer Registry.", ASCO Annual Meeting, CHICAGO, ABD, 1-7 Haziran 2015, vol.33, pp.1-1
Sevinc A., Seker M., Yildiz R., Cihan S., Kaplan M.A., Dane F., et al., "The clinical and pathologic characteristics of 400 gastrointestinal stroinal tumor patients from Turkey: The final results of the Turkish Anatolian Society of Medical Oncology Multicenter Registery", ASCO Annual Meeting, CHICAGO, ABD, 3-8 Haziran 2014, vol.32, pp.1-1
Coskun U., Gümüş M. , Uncu D., Ozkan M., Cicin I., Altundag K., et al., "Turkish Breast Cancer Registry: A multicenter epidemiologic study", ASCO Annual Meeting, CHICAGO, ABD, 2-7 Haziran 2014, vol.32, pp.1-1 (Group Author(s): Turkish OncoRegistry Study Grp )
Sendur M.A., Aksoy S., Uncu D., Demir H., Yuksel S., Ekinci A.S., et al., "EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER", ESMO Congress, MADRID, ISPANYA, 26 Eylül - 30 Haziran 2014, vol.25, pp.1-1
Ercelep O., Ekinci A.S., Bayoglu I.V., Uzunoglu S., Ulas A., Bozkurt O., et al., "Treatment and prognosis in mucosal. melanoma: An Anatolian Society of Medical Oncology Study.", ASCO Annual Meeting, CHICAGO, ABD, 2-7 Haziran 2014, vol.32, pp.1-1
Ozcelik M., Balvan Ercelep O., Guven Mert A., Yuksel S., Ozdemir P., Surmeli H., et al., "THREE DIFFERENT CHEMOTHERAPY COMBINATIONS WITH CONCURRENT THORACIC RADIATION FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER", ESMO Congress, MADRİD, ISPANYA, 26-30 Eylül 2014, vol.25, pp.1-1
Gümüş M. , Yasar N., Kayahan S., Yuksel S., Balvan O., Mert A.G., et al., "The relationship between collapsin response mediator protein-1 (CRMP 1) expression and histopathogic parameters and survival in patient with gastric cancer.", ASCO Annual Meeting, CHICAGO, ABD, 1-7 Haziran 2013, vol.31, pp.1-1
Aydin K., Uygur M.M., Odabas H., Korkmaz T., Yasar N., Dinc N., et al., "The relationship between tumor markers and histopathologic and demographic features of patients with breast cancer and their distinctive role in metastatic process.", ASCO Annual Meeting, CHICAGO, ABD, 3-8 Haziran 2013, vol.31, pp.1-1
Bilici A., Selcukbiricik F., Ustaalioglu B.B.O., Tural D., Seker M., Gümüş M. , et al., "Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer.", ASCO Annual Meeting, CHICAGO, ABD, 3-8 Haziran 2013, vol.31, pp.1-1
Gümüş M. , Dane F., Karabulut B., Uygun K., Orhan B., Aydin K., et al., "Interim results of observational study to determine K-ras mutation rates in patients with metastatic colorectal cancer in Turkey (TURKRAS study)", ECCO-ESMO Congress, AMSTERDAM, HOLLANDA, 27 Eylül - 1 Ekim 2013, vol.49, pp.S571-S571
Coskun U., Gunaydin Y., Ulas A., Balakan O., Inanc M., Inal A., et al., "NON-SMALL CELL LUNG CANCER IN YOUNG PATIENTS: CLINICOPATHOLOGICAL FEATURES", WORLD LUNG CANCER CONGRESS, SYDNEY, AVUSTRALYA, 27-30 Ekim 2013, vol.8, pp.S696-S696
Yasar N., Unal O.U., Geredeli C., Inal A., Berk V., Sari E., et al., "Efficacy and safety results of pemetrexed administration in non-small cell lung cancers, a multicenter study of the Association of Anatolian Medical Oncology.", ASCO Anuual Meeting, CHICAGO, ABD, 3-8 Haziran 2013, vol.31, pp.1-1 (Group Author(s): Anatolian Med Oncology )
Aydin K., Odabas H., Seker M., Korkmaz T., Yasar N., Sener N., et al., "COULD PRETREATMENT PET-CT STANDART UPTAKE VALUES HAVE A ROLE IN THE RESPONSE TO TREATMENT AND THE SURVIVAL IN PATIENTS WITH SMALL CELL LUNG CANCER?", WORLD LUNG CANCER CONGRESS, SYDNEY, AVUSTRALYA, 27-30 Ekim 2013, vol.8, pp.S1228-S1229
Bilici A., Selcukbiricik F., Ustaalioglu B.B., Seker M., Dane F., Aliustaoglu M., et al., "The evaluation of factors predicting recurrence and prognosis for patients with node-negative gastric cancer after curative resection", ECCO-ESMO Congress, AMSTERDAM, HOLLANDA, 27 Eylül - 1 Ekim 2013, vol.49, pp.S588-S588
Seker M., Gümüş M. , Barisik N.O., Dane F., Bozkurt S.U., Bilici A., et al., "The prognostic impact of survivin and REG1A in diffuse large B-cell lymphoma", ECCO-ESMO Congress, AMSTERDAM, HOLLANDA, 27 Eylül - 1 Ekim 2013, vol.49, pp.S848-S848
Yildiz R., Buyukberber S., Koca D., Korai L., Ciltas A., Unal O.U., et al., "The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.", ASCO Annual Meeting, CHICAGO, ABD, 3-8 Haziran 2013, vol.31, pp.1-1 (Group Author(s): ASMO )
Ahmet B., Uygun K., Kaya S., Ustaalioglu B.B.O., Yildiz R., Temiz S., et al., "A COMPARISON OF XELIRI PLUS BEVACIZUMAB WITH FOLFIRI PLUS BEVACIZUMAB AS FIRST-LINE SETTING IN PATIENTS WITH METASTATIC COLORECTAL CANCER", ESMO Congress, VİYANA, AVUSTURYA, 28 Eylül - 3 Ekim 2012, vol.23, pp.98-99
Abulkhair O., Uslu R., Sezgin C., Bueyuekberber S., Darwish T., Isikdogan A., et al., "Clinical outcomes among ErbB2+MBC patients treated with lapatinib-capecitabine after trastuzumab progression: Role of early switch to lapatinib (TYCO study).", SAN ANTONIO BREAST CANCER CONFERENCE, SAN ANTONIO, ABD, 2-8 Aralık 2012, vol.72, pp.1-1
Canhoroz M., Korkmaz T., Seber S., Bilici A., Okutur K., Toptas T., et al., "Correlation of high FDG uptake in PET/CT with poor prognosis in metastatic gastric adenocarcinoma.", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2011, vol.29, pp.1-1
Kaplan M.A., Isikdogan A., Gümüş M. , Arslan U.Y., Geredeli C., Ozdemir N., et al., "Childhood, adolescents, and young adults (age 25 and younger) colorectal cancer: A multicenter study", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2011, vol.29, pp.1-1
Arslan U.Y., Oksuzoglu O.B., Ozdemir N., Aksoy S., Alkis N., Durnali A.G., et al., "Outcome of operable male breast carcinoma: One hundred eighteen patients", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2011, vol.29, pp.1-1
Bilici A., Ustaalioglu B.B.O., Ercan S., Orcun A., Seker M., Salepci T., et al., "The Significance of the Changing of Serum M30 and M65 Values After Chemotherapy and Relationship Between These Values and Clinicopathological Factors in Patients With Advanced Gastric Cancer", ECCO-ESMO Congress, STOCKHOLM, ISVEÇ, 23-27 Eylül 2011, vol.47, pp.S474-S475
Turan N., Koca D., Dane F., Ozdemir N., Ustaalioglu B.B.O., Oztop I., et al., "The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer", ASCO Annual Meeting, CHICAGO, ABD, 3-7 Haziran 2011, vol.29, pp.1-1
Bilici A., Seker M., Oven U.B., Canpolat N., Tekinsoy B., Salepci T., et al., "CLINICAL ROLE OF 18F-FDG-PET/CT IN THE ASSESSMENT OF SUSPECTED RECURRENT GASTRIC CANCER AFTER INITIAL SURGICAL RESECTION: IS THERE ANY EFFECT OF FDG-PET/CT IN PATIENTS' MANAGEMENT?", ESMO Congress, MILAN, ITALYA, 8-12 Ekim 2010, vol.21, pp.84-84
Gümüş M. , Davidson N., Hurtado De Mendoza F., Brychta M., Donadio M., Kral A., et al., "TAXANE-BASED TREATMENT OPTIONS FOR PATIENTS WITH HER2-POSITIVE ADVANCED BREAST CANCER: RESULTS OF AN OBSERVATIONAL STUDY", 35. ESMO Congress, Milano, ITALYA, 8-12 Ekim 2010, vol.21, pp.103-103
Ustaalioglu O.B., Seker M., Bilici A., Salepci T., Kefeli U., Oncel M., et al., "THE IMPORTANCE OF LIVER METASTASECTOMY IN METASTATIC COLORECTAL CANCER PATIENTS: SINGLE CENTER EXPERIENCES", ESMO Congress, MILAN, ITALYA, 8-12 Ekim 2010, vol.21, pp.68-68
Bilici A., Ustaalioglu B.B.O., Orcun A., Ercan S., Seker M., Kefeli U., et al., "PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?", 35. ESMO Congress, Milan, ITALYA, 8-12 Ekim 2010, vol.21, pp.48-48
Bilici A., Ustaalioglu B.B.O., Orcun A., Ercan S., Seker M., Kefeli U., et al.,"PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?", , , , vol.21, pp.48-48
Camci C., Firoiu E., Gümüş M. , De Mendoza F.H., Chavez-Zamudio M.A., Davidson N., et al., "Factors associated with the choice of taxane monotherapy or combination in the management of advanced breast cancer: Results of an international observational study", ASCO Annual Meeting, CHICAGO, ABD, 29 Mayıs - 3 Haziran 2010, vol.28, pp.1-1
Ustaoglu M.A., Duman D., Gucun M., Konya V., Dane F., Gümüş M. , "Anthracycline-induced subclinical right ventricular dysfunction in adults", ESC CONGRESS, BARCELONA, ISPANYA, 29 Ağustos - 2 Eylül 2009, vol.30, pp.569-569
Yalçın Ş., Gümüş M. , Kılıçkap S., Alkış N., Alkış N., Alkış N., et al., "REGATE: Global Mide Kanseri Kayıt Çalışması Türkiye Verileri", 18.Ulusal Kanser Kongresi, ANTALYA, TÜRKIYE, 21-26 Nisan 2009, ss.17-17
Garip M., Gümüş M. , Dane F., Seker M., Bilici A., Ustaalioglu B.O., et al., "Factors affecting type of surgical treatment in patients with breast cancer", ASCO Annual Meeting, CHICAGO, ABD, 29 Mayıs - 3 Haziran 2009, vol.27, pp.1-1
Gümüş M. , Ustaalioglu B.O., Seker M., Bilici A., Salman T., Soenmez B., et al., "Single-center experiences of neoadjuvant systemic therapy in breast cancer: Individualization of the treatment", ASCO Annual Meeting, CHICAGO, ABD, 29 Mayıs - 2 Haziran 2009, vol.27, pp.1-1
Hallac K.S., Yavuzer D., Ergen C., Ege G.A., Ozdemir B.N., Cakir C., et al., "Nose skin metastasis of uterine endometrial adenocarcinoma: case report", European Congress of Pathology, BARCELONA, ISPANYA, 1-4 Ağustos 2009, vol.455, pp.298-298
Basaran G., Okkan S., Caglar H., Benekli M., Gümüş M. , Haydaroglu A., et al., "Immunohistochemically Defined T1N0 Breast Cancer Subgroups Have Different Clinical Outcomes. A Retrospective Turkish Oncology Group Study", SAN ANTONIO BREAST CANCER CONFERENCE, SAN ANTONIO, ABD, 6-9 Aralık 2009, vol.69, pp.701S-701S
Basaran G., Okkan S., Caglar H., Benekli M., Gümüş M. , Haydaroglu A., et al.,"Immunohistochemically Defined T1N0 Breast Cancer Subgroups Have Different Clinical Outcomes. A Retrospective Turkish Oncology Group Study", , , , vol.69, pp.701S-701S
Demirhan R., Mayadagli A., Parlak C., Kocak M., Ozkan A., Gümüş M. , "Our resection outcome in lung cancer: Evaluation of 45 consequential patients", ASCO Annual Meeting, CHICAGO, ABD, 29 Mayıs - 4 Haziran 2008, vol.26, pp.1-1
Ozturk A., Salepci T., Seker M., Gümüş M. , Uyarel H., Ustaalioglu B.B.O., et al., "THE ROLE OF ANGIOTENSIN II IN THE ETIOLOGY OF ARTERIAL VASOCONSTRICTION INDUCED BY 5-FLUOROURACIL", ESMO Congress, STOCKHOLM, ISVEÇ, 12-16 Eylül 2008, vol.19, pp.59-59
Dane F., Gümüş M. , Ozturk M.A., Cabuk D., Atasoy M.B., Yumuk P.F., et al., "Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience", ASCO Annual Meeting, CHICAGO, ABD, 29 Mayıs - 4 Haziran 2008, vol.26, pp.1-1
Barisik N.O., Keser S., Guel A., Cayirci M., Karadayi N., Gümüş M. , et al., "The relation of COX-2 expression with other prognostic parameters in invasive ductal carcinomas", European Congress of Pathology, İSTANBUL, TÜRKIYE, 2-3 Mayıs 2008, vol.452, pp.S146-S147
Bilgic M., Barişik N.Ö., Murtazaoglu M., Gezgin S., Karadayi N., Keser S., et al., "Cyclooxygenase expression in the colon adenocarcinomas and its relationship with other prognostic parameters", European Congress of Pathology, İSTANBUL, TÜRKIYE, 8-13 Eylül 2007, vol.451, pp.324-324
Cabuk D., Basaran G., İyikesici S., Ekenel M., Dane F., Teomete M., et al., "Outcome of adjuvant treatment in turkish breast cancer (BC) patients (PTS): Single institution experience", ESMO Congress, İSTANBUL, TÜRKIYE, 29 Eylül - 3 Ekim 2006, vol.17, pp.109-109
Dane F., Yumuk F., Gümüş M. , İyikesici S., Tufan A., Basaran G., et al., "Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital", ESMO Congress, İSTANBUL, TÜRKIYE, 29 Eylül - 3 Ekim 2006, vol.17, pp.129-129
Dane F., Gümüş M. , Yumuk P.F., İyikesici S., Ozturk A., Basaran G., et al., "Outcome of colon cancer patients receiving adjuvant chemotherapy in Marmara University Hospital", ESMO Congress, İSTANBUL, TÜRKIYE, 29 Eylül - 3 Ekim 2006, vol.17, pp.130-130
Ozden S.A., Ozgen Z., Ozyurt H., Salepçi T., Gümüş M. , Dizdar N., et al., "Use of new chemotherapy agents in metastatic breast cancer", ESMO Congress, İSTANBUL, TÜRKIYE, 29 Eylül - 3 Ekim 2006, vol.17, pp.92-92
Yumuk P.F., Gümüş M. , Kaya H., Alam K., Dane F., Güllüoğlu B., et al., "Association between presence of HPV DNA and P53 in breast cancer patients", ESMO Congress, İSTANBUL, TÜRKIYE, 29 Eylül - 3 Ekim 2006, vol.17, pp.110-111
Cetiner M., Salepçi T., Atesoglu E.B., Gümüş M. , Guven A., Undar L., et al., "Rituximab-CHOP versus CHOP alone in patients with diffuse large B cell lymphoma.", ASH Annual Meeting, Orlando, ABD, 9-12 Aralık 2006, vol.108, pp.259B-260B
Gemici C., Demir O., Salepci T., Gümüş M. , Mayadagli A., Seseogullari O., "Uracil-tegafur (UFT) based radiochemotherapy in adjuvant treatment of resected high risk gastric cancer.", ASCO Annual Meeting, Orlando, ABD, 13-17 Mayıs 2005, vol.23, pp.351S-351S
Gümüş M. , Palak B., Iyikesici S., Yumuk P., Seker M., Topal A., et al., "Outcome of elderly patients with advanced non-small cell lung cancer.", ASCO Annual Meeting, Orlando, ABD, 13-17 Mayıs 2005, vol.23, pp.706S-706S
Yumuk P., Turhal N., Gümüş M. , Hatabay N., Turken O., Ozkan A., et al.,"Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).", , , , vol.22, pp.696S-696S
Cabuk D., Yumuk P., Abacioglu U., Demir G., Dane F., Gümüş M. , et al., "Is the incidence of anal canal cancers different in Moslem societies?", American Society Of Clinical Oncology Annual Meeting, NEW ORLEANS, ABD, 1-5 Haziran 2004, vol.22, pp.371S-371S
Yumuk P., Turhal N., Gümüş M. , Hatabay N., Turken O., Ozkan A., et al., "Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).", American Society Of Clinical Oncology Annual Meeting, NEW ORLEANS, ABD, 1-5 Haziran 2004, vol.22, pp.696S-696S
Gümüş M. , Yumuk F., Salepci T., Aliustacglu M., Ekenel M., Basaran G., et al., "Human papilloma virus: Is it a new etiological factor in breast cancer?", American Society Of Clinical Oncology Annual Meeting, NEW ORLEANS, ABD, 1-5 Haziran 2004, vol.22, pp.868S-868S
Dane F., Turhal N.S., Lyikesici S., Gümüş M. , Yumuk P.F., Basaran G., et al., "Clinical features and adjuvant treatment outcomes of colon cancer (cc) in two outpatient populations of Knoxville, Tennessee and Istanbul, Turkey", ESMO Congress, VİYANA, AVUSTURYA, 29 Ekim - 2 Kasım 2004, vol.15, pp.95-95
İyikesici S., Turhal N.S., Yumuk P.F., Dane F., Gümüş M. , Basaran G., et al., "Treatment outcomes in non-small cell lung cancer (NSCLC) patients: Comparison between Marmara University, Istanbul, Turkey and Knoxville, Tennessee", ESMO Congress, VİYANA, AVUSTURYA, 29 Ekim - 2 Kasım 2004, vol.15, pp.195-196
Sakar B., Basaran M., Gümüş M. , Yazar A., Argon A., Aykan N.F., "Clinicopathologic factors influencing survival of patients with bile duct and gallbladder carcinoma", ESMO Congress, VİYANA, AVUSTURYA, 29 Ekim - 2 Kasım 2004, vol.15, pp.243-244
Aliustaoglu M., Gümüş M. , Midi A., Celikel C., Ekenel M., Yumuk F., et al., "Prognostic value of thymidylate synthase and cox-2 expression in colorectal cancer patients' tumors.", ASCO ANNUAL MEETİNG, NEW ORLEANS, ABD, 1-7 Haziran 2004, vol.22, pp.301S-301S
Koldas M., Gümüş M. , Seval H., Karaoglu H., Colak A., Kural A., et al., "Role of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in patients with non-small cell lung cancer", ESMO Congress, VİYANA, AVUSTURYA, 29 Ekim - 2 Kasım 2004, vol.15, pp.187-187
Gümüş M. , Topal A., Baloglu G., Ozkan Z., Güler Ş., Aliustaoglu M., et al., "The serum leptin levels in patients with breast cancer and its relationship with the tumor characteristics", ESMO Congress, VİYANA, AVUSTURYA, 29 Ekim - 2 Kasım 2004, vol.15, pp.60-60
Basaran G.A., Ekenel M., Demirkalem P., Çakır T., Güllüoğlu B., Gümüş M. , et al., "Clinical outcome of breast cancer (BC) patients (pts) with pT1N0M0 disease", ESMO Congress, VİYANA, AVUSTURYA, 29 Ekim - 2 Kasım 2004, vol.15, pp.68-68
Gemici C., Mayadagli A., Salepci T., Tugrul F., Parlak C., Gümüş M. , et al., "Impact of INT-0116 Trial on adjuvant treatment of gastric cancer", ASCO ANNUAL MEETİNG, NEW ORLEANS, ABD, 1-7 Haziran 2004, vol.22, pp.376S-376S
Kitap ve Kitap Bölümleri
Gümüş M. , "Jinekolojik Tümörler", Jinekolojik Tümörler, Aydıner A, Aslay I, Berkman S., Ed., Nobel Yayın Dağıtım, İstanbul, ss.1-309, 2016
Diğer Yayınlar
Bilimsel Dergilerdeki Görevler
Anadolu Kliniği, Editörler Kurulu Üyesi, 01.05.2016 - Devam Ediyor
Journal of Oncological Sciences, Editörler Kurulu Üyesi, 01.03.2016 - Devam Ediyor
Yeni Üroloji Dergisi, Danisma Kurul Üyesi, 01.10.2013 - Devam Ediyor
Türkiye Klinikleri Tıbbi Onkoloji, Özel Sayi Editörü, 01.01.2012 - 31.12.2012
Remisyon Güncel Onkoloji Dergisi, Danisma Kurul Üyesi, 01.06.2010 - Devam Ediyor
Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Danisma Kurul Üyesi, 01.01.2006 - Devam Ediyor
Bilimsel Dernek, Organizasyon ve Kuruluşlardaki Üyelikler / Görevler
Türk Tıbbi Onkoloji Derneği, , Üye, 01.12.2016 - Devam Ediyor
Sağlık Bakanlığı, Geleneksel ve Tamamlayıcı Tıp Bilimsel Kurulu, Üye, 01.04.2016 - Devam Ediyor
TÜBA, Kanser Çalışma Grubu, Üye, 01.04.2016 - Devam Ediyor
Türkiye Yeşilay Cemiyeti, , Üye, 01.03.2015 - Devam Ediyor
TÜBİTAK, SBAG-Sağlık Bilimleri Araştırma Grubu, Üye, 01.04.2014 - Devam Ediyor
ESMO European Society of Medical Oncology, , Üye, 01.01.2004 - Devam Ediyor
Katıldığı Bilimsel Kongre / Sempozyum ve Bilimsel Toplantılar
Klinik Araştırmalarda Faz Çalışmaları ve Etik Kurallar Çalıştayı, İstanbul, Ocak 2017
II.Cerrahi, Gastroenterohepatoloji ve Onkoloji Günleri, , Mart 2017
Genitourinary Cancer Symposium 2017, Florida, Şubat 2017
IV:Nadir Tümörler Sempozyumu, --Seçiniz--, Şubat 2017
5.Onkolojide Arayışlar Sempozyumu, İzmir, Kasım 2016
Tüba Geleneksel ve Tamamlayıcı Tıp Ürünlerinin Ruhsatlandırılması Sempozyumu, , Aralık 2016
12.Ulusal Onkolojik Araştırmalar Çalıştayı, Antalya, Ekim 2016
6.International Gastrointestinal Cancer Conference, Antalya, Aralık 2016
ASCO Annual Meeting 2016, Illinois, Haziran 2016
VII.Ulusal Akciğer Kanseri Kongresi, Antalya, Kasım 2016
TKRCD Sonbahar Sempozyumu Kolorektal Kanser, Eskişehir, Kasım 2016
3. Ulusal İmmuno-Onkoloji Kongresi, Antalya, Mayıs 2016
PEGF/USV/P3/003 Investigator Meeting, Athína, Ağustos 2015
ASCO Annual Meeting 2015, Illinois, Haziran 2015
21.Ulusal Kanser Kongresi, Antalya, Nisan 2015
Prostat Kanseri Çalıştayı, Ankara, Aralık 2015
2. Ulusal İmmuno-Onkoloji Kongres, Antalya, Mayıs 2015
TÜBA-Kanser Tedavisinde Paydaşlar Arası Koordinasyonda Yaşanan Proplemler Sempozyumu, Ankara, Aralık 2014
İstanbul Bilim Üniversitesi 6. Onkoloji Günleri, Bolu, Aralık 2014
Metastatik Melanom Tedavisinde Multidisipliner Yaklaşım Çalıştayı, Sakarya, Ağustos 2014
Meme Kanserinde Tartışmalı Konular, Kayseri, Şubat 2014
Ulusal Kanser Politikaları Çalıştayı, Ankara, Haziran 2014
ASCO Annual Meeting 2014, Illinois, Haziran 2014
20.Ulusal Kanser Kongresi, Antalya, Nisan 2013
ASCO Annual Meeting 2013, Illinois, Haziran 2013
19.Ulusal Kanser Kongresi, Antalya, Nisan 2011
Onkoloji Hemşireliği Sempozyumu, İstanbul, Mayıs 2011
13.Ulusal İç Hastalıkları Kongresi, Antalya, Ekim 2011
4.Üroonkoloji Kış Sempozyumu, Hatay, Şubat 2011
ESMO Course Essentials of Medical Oncology, İstanbul, Şubat 2010
Baş-Boyun ve Akciğer Kanserleri Sempozyumu, Bursa, Şubat 2009
18.Ulusal Kanser Kongresi, Antalya, Nisan 2009
17.Ulusal Kanser Kongresi, Antalya, Nisan 2007
26.Ulusal Diyabet Kongresi, Gaziantep, Mayıs 2000
Erektil Disfonksiyon ve Sildenafil, Antalya, Nisan 2000
IV Ovroosiyo Halqaro Gastroenterologiya Kongressi, Toskent, Mayıs 2000
Bilimsel Hakemlikler
Anadolu Kliniği, Dergide Hakemlik, Ocak 2017
Bezmialem Science, Dergide Hakemlik, Ocak 2017
Türkiye Klinikleri Journal Of Case Reports, Dergide Hakemlik, Ocak 2017
Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Dergide Hakemlik, Aralık 2016
Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Dergide Hakemlik, Kasım 2015
Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Dergide Hakemlik, Ağustos 2011
Kartal Eğitim Araştırma Hastanesi Tıp Dergisi, Dergide Hakemlik, Nisan 2011
Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Dergide Hakemlik, Aralık 2010
Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Dergide Hakemlik, Aralık 2010
Etkinlik Organizasyonu
Klinik Araştırmalarda Faz Çalışmaları ve Etik Kurallar Çalıştayı, Bilim Kurulu Üyesi, , TÜRKIYE, Ocak 2017
3.Ulusal İmmuno-Onkoloji Kongresi, Düzenleme Kurulu Üyesi, , TÜRKIYE, Mayıs 2016
2.Ulusal İmmuno-Onkoloji Kongresi, Bilim Kurulu Üyesi, , TÜRKIYE, Mayıs 2015
21. Ulusal Kanser Kongresi, Düzenleme Kurulu Üyesi, , TÜRKIYE, Nisan 2015
Onkoloji Hemşireliği Sempozyumu, Bilim Kurulu Üyesi, , TÜRKIYE, Mayıs 2011
Kırklareli Üniversitesi Onkoloji Hemşireliği Sempozyumu, Düzenleme Kurulu Başkanı, , TÜRKIYE, Mayıs 2011
Davetli Kongre ve Sempozyum Görevleri
IV.Nadir Tümörler Sempozyumu, Oturum Başkanı, , TÜRKIYE, 2017
Klinik Araştırmalarda Faz Çalışmaları ve Etik Kurallar Çalıştayı, Moderatör, , TÜRKIYE, 2017
II.Cerrahi,Gastroenterohepatoloji ve Onkoloji Günleri, Oturum Başkanı, , TÜRKIYE, 2017
12.Ulusal Onkolojik Araştırmalar Çalıştayı, Oturum Başkanı, , TÜRKIYE, 2016
VII. Ulusal Akciğer Kanseri Kongresi, Oturum Başkanı, , TÜRKIYE, 2016
6.International Gastrointestinal Cancer Conference, Moderatör, , TÜRKIYE, 2016
TKRCD Sonbahar Sempozyumu Kolorektal Kanser, Davetli Konuşmacı, , TÜRKIYE, 2016
Prostat Kanserine Olgular Eşliğinde Multidisipliner Yaklaşım, Panelist, , TÜRKIYE, 2016
5.Onkolojide Arayışlar Sempozyumu, Oturum Başkanı, , TÜRKIYE, 2016
3.Ulusal İmmuno-Onkoloji Kongresi, Oturum Başkanı, , TÜRKIYE, 2016
2.İmmuno-Onkoloji Kongresi, Oturum Başkanı, , TÜRKIYE, 2015
21.Ulusal Kanser Kongresi, Davetli Konuşmacı, , TÜRKIYE, 2015
2.İmmuno-Onkoloji Kongresi, Davetli Konuşmacı, , TÜRKIYE, 2015
Metastatik Melanom Tedavisinde Multidisipliner Yaklaşım Çalıştayı, Oturum Başkanı, , TÜRKIYE, 2014
Meme Kanserinde Tartışmalı Konular, Davetli Konuşmacı, , TÜRKIYE, 2014
İstanbul Bilim Üniversitesi 6.Onkoloji Günleri, Davetli Konuşmacı, , TÜRKIYE, 2014
20.Ulusal Kanser Kongresi, Oturum Başkanı, , TÜRKIYE, 2013
19.Ulusal Kanser Kongresi, Davetli Konuşmacı, , TÜRKIYE, 2011
Onkoloji Hemşireliği Sempozyumu, Davetli Konuşmacı, , TÜRKIYE, 2011
4.Üroonkoloji Kış Sempozyumu, Davetli Konuşmacı, , TÜRKIYE, 2011
13.Ulusal İç Hastalıkları Kongresi, Davetli Konuşmacı, , TÜRKIYE, 2011
ESMO Course Essentials of Medical Oncology, Oturum Başkanı, , TÜRKIYE, 2010
18.Ulusal Kanser Kongresi, Panelist, , TÜRKIYE, 2009
Baş-Boyun ve Akciğer Kanserleri Sempozyumu, Davetli Konuşmacı, , TÜRKIYE, 2009
Google Akademik Linkleri ve H İndeksi
Google Akademik Linkleri : 0
Web Of Science H İndeksi : 16
Atıflar
ISI Web of Science Dizinlerinde Taranan Dergilerdeki Atıflar : 915
Diğer Uluslararası Yayınlardaki Atıflar : 0
Ulusal Yayınlardaki Atıflar : 0
Katalog Bilgileri
Dokumanlar
Tarih D. Türü Döküman Tanımı / Adı İndir
Akademik Veri Yönetim Sistemi | All Rights Reserved | Abis Teknoloji © 2018
İstanbul Medeniyet Üniversitesi BAP Koordinasyon Birimi